Cover
| Cover | Oct. 10, 2023 |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Current Report on Form 8-K/A (the “Amendment”) is being filed as an amendment to the Current Report on Form 8-K filed by Calidi Biotherapeutics, Inc. (the “Company”) on October 16, 2023 (the “Original 8-K”) to add the information described herein. |
| Document Period End Date | Oct. 10, 2023 |
| Entity File Number | 001-40789 |
| Entity Registrant Name | CALIDI BIOTHERAPEUTICS, INC. |
| Entity Central Index Key | 0001855485 |
| Entity Tax Identification Number | 86-2967193 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 4475 Executive Drive |
| Entity Address, Address Line Two | Suite 200 |
| Entity Address, City or Town | San Diego |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 92121 |
| City Area Code | (858) |
| Local Phone Number | 794-9600 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Common stock, par value $0.0001 per share | |
| Title of 12(b) Security | Common stock, par value $0.0001 per share |
| Trading Symbol | CLDI |
| Security Exchange Name | NYSEAMER |
| Warrants, each whole warrant exercisable for one share of common stock | |
| Title of 12(b) Security | Warrants, each whole warrant exercisable for one share of common stock |
| Trading Symbol | CLDI WS |
| Security Exchange Name | NYSEAMER |